Thirty-six states in America have legalized cannabis for medical use, and an estimated 3.6 million individuals are registered as medical cannabis patients in the United States. However, federal law classifies cannabis as a Schedule I controlled substance with no accepted medical use; cannabis is ranked right alongside hard drugs such as cocaine and heroin. Consequently, insurance companies refuse to cover individuals who use medical cannabis to treat work-related injuries. Instead, most of these patients have to pay for their medical cannabis out of pocket.
In Pennsylvania, however, a workers’ compensation judge made a historic and possibly precedent-setting ruling after declaring that an employee who was hurt while on the job and used medical marijuana to ease her pain deserved to be compensated by her former employer’s insurance provider. According to the plaintiff’s lawyer, Dana Kaufman from Kaufman Workers’ Compensation Law, this is the first time there has been such a ruling…
NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.